Literature DB >> 28875363

Implantation of Unibody Single-Branched Stent Graft for Patients with Type B Aortic Dissections Involving the Left Subclavian Artery: 1-Year Follow-Up Outcomes.

He Huang1, Yuanyong Jiao2, Yepeng Zhang1, Yuelin Zhu1, Zhao Liu1, Tong Qiao1, Changjian Liu1, Xiwei Zhang3, Min Zhou4.   

Abstract

OBJECTIVE: To report the early results of castor device, a kind of unibody single-branched stent graft, in the treatment of type B aortic dissection (TBAD) involving the LSA.
METHODS: From April 2013 to February 2014, 21 patients with TBADs underwent TEVAR with LSA revascularization by unibody single-branched stent grafts. Three patients with penetrating aortic ulcers in the aortic arch received additional reconstruction of left common carotid artery with chimney technique. Follow-up evaluations were conducted with computed tomography angiography (CTA) at 6, 12 months and annually after that.
RESULTS: All of the proximal entry tears were completely excluded. Good patency of the grafts was found in all cases. A small type I endoleak occurred in one patient during the procedure. Perioperative mortality is null, and there was no occurrence of serious complications. All patients completed the follow-up except one lost contact after discharge. One death occurred within 6 months after the operation, resulting from myocardial infarction, considered unrelated to the stent implantation. No endoleak occurred during follow-up. One compression of a chimney stent and one twist of side branch graft of castor were observed in 2 different patients, respectively. In other cases, CTA scans showed good patency of both the branched and chimney grafts. Two patients had partial thrombosis of the false lumen during follow-up. In other patients, complete thrombosis in the false lumen in thoracic aorta was revealed.
CONCLUSION: The single-branched stent graft was safe and efficient in the 1-year follow-up. Further studies are required to determine its long-term outcomes.

Entities:  

Keywords:  Aortic dissection; Left subclavian artery; Single-branched stent graft; Thoracic endovascular aortic repair

Mesh:

Year:  2017        PMID: 28875363     DOI: 10.1007/s00270-017-1748-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Status of branched endovascular aortic arch repair.

Authors:  Theodorus M van Bakel; Hector W de Beaufort; Santi Trimarchi; Massimiliano M Marrocco-Trischitta; Jean Bismuth; Frans L Moll; Himanshu J Patel; Joost A van Herwaarden
Journal:  Ann Cardiothorac Surg       Date:  2018-05

2.  Volume-Outcome Relationships in Surgical and Endovascular Repair of Aortic Dissection.

Authors:  Alexander A Brescia; Himanshu J Patel; Donald S Likosky; Tessa M F Watt; Xiaoting Wu; Raymond J Strobel; Karen M Kim; Shinichi Fukuhara; Bo Yang; G Michael Deeb; Michael P Thompson
Journal:  Ann Thorac Surg       Date:  2019-08-07       Impact factor: 4.330

3.  Hybrid Arch Repair with Supra-Aortic Debranching and Using Castor Stent-Graft.

Authors:  Xijie Gao; Guohong Liu; Jun Lu; Jianbo Zhao
Journal:  Thorac Cardiovasc Surg Rep       Date:  2022-06-25

4.  Single-center experience with a unibody single-branched stent graft for zone 2 thoracic endovascular aortic repair.

Authors:  Xiang Kong; Peng Ruan; Jiquan Yu; Tianshu Chu; Lei Gao; Hui Jiang; Jianjun Ge
Journal:  Front Cardiovasc Med       Date:  2022-09-09

5.  Comparison of techniques for left subclavian artery preservation during thoracic endovascular aortic repair: A systematic review and single-arm meta-analysis of both endovascular and surgical revascularization.

Authors:  Yuchong Zhang; Xinsheng Xie; Ye Yuan; Chengkai Hu; Enci Wang; Yufei Zhao; Peng Lin; Zheyun Li; Fandi Mo; Weiguo Fu; Lixin Wang
Journal:  Front Cardiovasc Med       Date:  2022-09-15

6.  Early experience and technical aspects of physician-modified fenestration in thoracic endovascular aortic repair for aortic arch pathologies.

Authors:  Xin Li; Quanming Li; Weichang Zhang; Ming Li; Hao He; Mingyao Luo; Kun Fang; Chenzi Yang; Jieting Zhu; Chang Shu
Journal:  J Int Med Res       Date:  2019-09-23       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.